Joachim A.
- Country
- The Netherlands
- Department
- 7001: Pulmonary Department
Research Overview
- Phase I Study of BAY2927088 in Patients with Advanced Non-Small Cell Lung Cancer Harboring EGFR and/or HER2 Mutations
- Phase 2 Open‑Label Multicohort Study of Rinatabart Sesutecan Monotherapy in Patients with Locally Advanced or Metastatic Non‑Small Cell Lung Cancer
- A Phase 3 Randomized Open-Label Study Comparing Sigvotatug Vedotin and Docetaxel in Adults with Previously Treated Non-Small Cell Lung Cancer
Data & Insights
Has run more than one trial at 192 of 403 partner sites.
Specializations
Lung Cancer Research
The investigator specializes in both small-cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) treatment approaches. Their research encompasses innovative therapeutic strategies for both limited and extensive disease stages.
- Combined Chemoradiotherapy Approaches
- Immunotherapy Integration
- Advanced Treatment Protocols
Particular focus is placed on examining novel therapeutic combinations including immunotherapy agents and targeted treatments for various lung cancer subtypes.
Mesothelioma Studies
The investigator conducts research in pleural mesothelioma treatment modalities, exploring multiple therapeutic approaches. Their work includes evaluation of both conventional and innovative treatment strategies.
- Dendritic Cell Therapy
- Molecular Pathway Targeting
- Combination Treatment Approaches
Research includes investigation of surgical interventions combined with immunotherapy and evaluation of novel therapeutic compounds.
Thoracic Oncology
Expertise extends to rare thoracic malignancies including thymic carcinoma and thymoma. The investigator explores various treatment modalities for thoracic cancers.
- Immunotherapy Applications
- Therapeutic Cancer Vaccines
- Novel Drug Development
Research focuses on developing and evaluating new therapeutic approaches for patients with advanced thoracic malignancies.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.